Elizabeth Pharmacy is seeking a pharmacy technician. If you are interested contact us at 908-994-1525.

FDA

Food and Drug Administration

  • Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to modernize drug development, improve efficiency and promote innovation of targeted therapies

    FDA issues two guidance documents to provide drug developers greater clarity and direction as they pursue the next generation of therapies and treatments for patients.

    https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm623411.htm
    Mon, 15 Oct 2018 10:33:00 -0400
  • FDA advances investigation into whether more than 40 e-cigarette products are being illegally marketed and outside agency's compliance policy

    FDA advances investigation into whether more than 40 e-cigarette products are being illegally marketed and outside agency's compliance policy

    https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm623256.htm
    Fri, 12 Oct 2018 10:11:00 -0400
  • FDA approves new DNA-based test to determine blood compatibility

    FDA approves new DNA-based test to determine blood compatibility.Test is first of this type approved to report genotypes as final results

    https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm623195.htm
    Thu, 11 Oct 2018 16:32:00 -0400
  • Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance the development of generic copies of complex drugs to improve patient access to medicines

    FDA issued a new series of guidance documents that will advance the development of generic transdermal and topical delivery systems

    https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm622735.htm
    Tue, 09 Oct 2018 09:34:00 -0400
  • La FDA aprueba el uso ampliado de Gardasil 9 para incluir a personas de 27 a 45 años de edad

    La FDA aprueba el uso ampliado de Gardasil 9 para incluir a personas de 27 a 45 años de edad

    https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm622846.htm
    Tue, 09 Oct 2018 17:16:00 -0400
  • FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old

    FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old

    https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm622715.htm
    Fri, 05 Oct 2018 16:48:00 -0400
  • FDA allows marketing of first self-fitting hearing aid controlled by the user

    FDA allows marketing of a new device, the Bose Hearing Aid, intended to amplify sounds for individuals 18 years or older with perceived mild to moderate hearing impairment (hearing loss). This is the first hearing aid authorized for marketing by the FDA that enables the user to fit, program and control the hearing aid on his or her own, without assistance from a health care provider.

    https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm622692.htm
    Fri, 05 Oct 2018 12:39:00 -0400
  • Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency actions to further deter ‘gaming’ of the generic drug approval process by the use of citizen petitions

    FDA issues revised guidance to allow for a more efficient approach to 505(q) petitions and focus more resources on scientific reviews.

    https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm622252.htm
    Tue, 02 Oct 2018 09:56:00 -0400
  • Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA’s efforts to strengthen the agency’s medical device cybersecurity program as part of its mission to protect patients

    FDA’s efforts to strengthen the agency’s medical device cybersecurity program as part of its mission to protect patients

    https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm622074.htm
    Mon, 01 Oct 2018 12:38:00 -0400
  • FDA approves a new antibacterial drug to treat a serious lung disease using a novel pathway to spur innovation

    The FDA approved the first antibacterial drug under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD). LPAD was created by Congress to spur development of drugs targeting serious infections in limited patient populations with unmet need.

    https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm622048.htm
    Fri, 28 Sep 2018 17:19:00 -0400
  • FDA authorizes first next generation sequencing-based test to detect very low levels of remaining cancer cells in patients with acute lymphoblastic leukemia or multiple myeloma

    FDA authorizes first next generation sequencing-based test to detect very low levels of remaining cancer cells in patients with acute lymphoblastic leukemia or multiple myeloma

    https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm622004.htm
    Fri, 28 Sep 2018 15:23:00 -0400
  • FDA approves first treatment for advanced form of the second most common skin cancer

    FDA approves Libtayo (cemiplimab-rwlc) for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or curative radiation. This is the first FDA approval of a drug specifically for advanced CSCC.

    https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm622044.htm
    Fri, 28 Sep 2018 16:55:00 -0400
  • Statement from FDA Commissioner Scott Gottlieb, M.D., on modernizing standards of identity and the use of dairy names for plant-based substitutes

    FDA issues a request for information to solicit feedback on how consumers are using plant-based substitutes for milk, cheese and other dairy foods.

    https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm621824.htm
    Thu, 27 Sep 2018 09:44:00 -0400
  • Statement by FDA Commissioner Scott Gottlieb, M.D., on preparations for the upcoming flu season and vaccinations

    Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA’s role in preparing for flu season

    https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm621785.htm
    Thu, 27 Sep 2018 11:12:00 -0400
  • Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA commitment to disclose retailer information for certain food recalls to improve consumer safety

    Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA commitment to disclose retailer information for certain food recalls to improve consumer safety

    https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm621692.htm
    Wed, 26 Sep 2018 09:43:00 -0400
  • Remarks from Anna Abram as prepared for delivery to the 2018 Intergovermental Meeting on Drug Compounding

    Remarks by FDA’s Anna Abram to the 2018 Intergovermental Meeting on Drug Compounding

    https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm621600.htm
    Tue, 25 Sep 2018 11:38:00 -0400
  • FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases

    FDA has awarded 12 new clinical trial research grants to enhance the development of medical products for patients with rare diseases

    https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm621490.htm
    Mon, 24 Sep 2018 14:23:00 -0400
  • FDA takes important steps to encourage appropriate and rational prescribing of opioids through final approval of new safety measures governing the use of immediate-release opioid analgesic medications

    FDA takes important steps to encourage appropriate and rational prescribing of opioids through final approval of new safety measures governing the use of immediate-release opioid analgesic medications.

    https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm620935.htm
    Tue, 18 Sep 2018 13:59:00 -0400
  • Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s ongoing efforts to prevent foodborne outbreaks of Cyclospora

    he safety of the American food supply is one of the U.S. Food and Drug Administration’s highest priorities. A key part of our work in this space focuses on implementing the principles and measures of the FDA Food Safety Modernization Act (FSMA). The actions directed by FSMA are designed to prevent foodborne illness and food safety problems from happening.

    https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm620867.htm
    Tue, 18 Sep 2018 16:47:00 -0400
  • Statement from FDA Commissioner Scott Gottlieb, M.D., on launch of ‘The Real Cost’ Youth E-Cigarette Prevention Campaign amid evidence of sharply rising use among kids

    Statement from FDA Commissioner Scott Gottlieb, M.D., on launch of ‘The Real Cost’ Youth E-Cigarette Prevention Campaign amid evidence of sharply rising use among kids.

    https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm620791.htm
    Tue, 18 Sep 2018 09:34:00 -0400

The views and opinions expressed in this feed are those of the authors and do not necessarily reflect the official policy or position of Elizabeth Pharmacy. Elizabeth Pharmacy does not warrant the accuracy, timeliness or completeness of the information contained on this feed. If you have a particular complaint about something you’ve found on this web site, feel free to contact us.